Circulating mi<scp>RNA</scp>s in myasthenia gravis: miR‐150‐5p as a new potential biomarker

Abstract

WE PROPOSE THAT THE VALIDATED MIRNAS: hsa-miR150-5p, hsa-miR21-5p, and hsa-miR27a-3p can serve as novel serum biomarkers in AChR+ MG. Hsa-miR-150-5p could be a helpful marker to monitor disease severity.